Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Aprea Therapeutics Inc., 3 years.
Aprea Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Aprea Therapeutics Inc. June 20, 202498.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Aprea Therapeutics Inc. | Grant or award | +3,135 | — | — |
| Jun 5, 2025 | Aprea Therapeutics Inc. | Grant or award | +1,045 | — | — |
| Jun 20, 2024 | Aprea Therapeutics Inc. | Grant or award | +1,045 | — | — |
| Aug 23, 2023 | Aprea Therapeutics Inc. | Grant or award | +500 | — | — |
| Aug 23, 2022 | Aprea Therapeutics Inc. | Derivative conversion | +49,280 | — | — |
| Aug 23, 2022 | Aprea Therapeutics Inc. | Derivative conversion | +271,870 | — | — |
Questions about Rifat Pamukcu
What boards is Rifat Pamukcu on?
Rifat Pamukcu sits on the board of Aprea Therapeutics Inc.
How long has Rifat Pamukcu served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.